FdaApplication
NDA 214826
Identifiers
- fda_app_no: NDA214826
Properties
| Property | Value |
|---|---|
| applicant_name | ALMATICA PHARMA LLC |
| application_type | NDA |
| approval_date | 2021-08-27 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LOREEV XR | LORAZEPAM | 2MG | CAPSULE, EXTENDED RELEASE;ORAL |
| LOREEV XR | LORAZEPAM | 1MG | CAPSULE, EXTENDED RELEASE;ORAL |
| LOREEV XR | LORAZEPAM | 1.5MG | CAPSULE, EXTENDED RELEASE;ORAL |
| LOREEV XR | LORAZEPAM | 3MG | CAPSULE, EXTENDED RELEASE;ORAL |
4 products